Scientific deep-dive

Capsaicin and Capsinoids for Weight Loss: Eight Measures, Eight Nulls

A dose-response meta-analysis of 13 randomized trials and 838 participants found no effect of capsinoids on body weight, BMI, waist circumference, fat mass, fat-free mass, waist-hip ratio, visceral fat or body fat percentage.

By Nora Bissett · Pricing Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
5 min read·2 citations

Part of Weight-loss supplements and diet trends: what the trials show

Capsinoids, the non-pungent relatives of the compound that makes chili hot, are sold on the theory that they raise energy expenditure. A systematic review and dose-response meta-analysis pooled 13 randomized trials and 838 participants and measured eight things: body weight, BMI, waist circumference, waist-hip ratio, fat mass, fat-free mass, visceral fat area and body fat percentage. None of them changed.[1]

The eight nulls

Capsinoid supplementation against control, 13 trials, 838 participants, 19 effect sizes.[1]
MeasureP value
Body weight0.230
Body mass index0.182
Waist circumference0.611
Waist-hip ratio0.599
Fat mass0.946
Fat-free mass0.917
Visceral fat area0.836
Percentage body fat0.973

Several of those p values sit close to 1. These are not near-misses in an underpowered analysis; they are results centered on no difference at all.

The subgroup that gets quoted

The same paper reports one positive finding: in trials conducted on overweight participants that lasted twelve weeks or longer, there was a significant and modest reduction in body weight. That sentence is the one you will meet on a product page, usually without the eight nulls it sits inside.[1]

The same paper undercuts its own subgroup. Its dose-response analysis found no significant non-linear association between capsinoid dosage and body weight, and no significant non-linear association between study duration and body weight either. If longer use produced more effect, that analysis is where it would be expected to show. It did not, although a non-linear test cannot rule out a simple straight-line trend.

A subgroup finding inside an overall null result is a hypothesis, not a conclusion. Split any dataset enough ways and some slice will reach significance. That does not make it false. It makes it something for the next trial to test, and that is what the authors ask for: well-designed randomized trials with larger samples and longer duration.

What about the brown fat studies?

Capsinoids have been shown to activate brown adipose tissue and to increase energy expenditure in laboratory conditions,[2] and that is the mechanism the marketing rests on. The mechanism is real. The meta-analysis above is what happened when the mechanism was tested against the outcome: eight measures of body composition, none of which moved.

Capsinoids can raise energy expenditure in the lab, yet across 13 trials none of eight body composition measures moved.

For where the evidence sits on other supplements sold for weight, our supplement evidence grader carries a graded entry with its primary study for sixteen of them, our review of GLP-1 supplements covers berberine, lemon flavonoid, saffron and probiotics, and CLA and green tea extract get the same treatment. For what does move body composition during weight loss, see protein targets and the lab panel and bone density and exercise.

Frequently Asked Questions

A dose-response meta-analysis of 13 randomized trials with 838 participants found no significant effect of capsinoid supplementation on body weight, BMI, waist circumference, waist-hip ratio, fat mass, fat-free mass, visceral fat area or percentage body fat.
Capsinoids do activate brown adipose tissue and can increase energy expenditure under laboratory conditions. The meta-analysis is what happened when that mechanism was tested against actual body composition, and none of the eight measures moved.
A subgroup of trials in overweight participants lasting twelve weeks or more did show a modest significant reduction in body weight. It sits inside an overall null result, and the same paper's dose-response analysis found no significant non-linear relationship between duration and weight, which does not support the subgroup being a real duration effect.
The meta-analysis addressed efficacy rather than safety. Capsinoids are the non-pungent analogs of capsaicin and are generally consumed as food compounds, but supplement doses are a different matter from culinary ones and are not standardized.

References

  1. 1.Sheikhhossein F, Amini MR, Askari M, et al. The effects of capsinoids supplementation on body composition and anthropometric measures: A systematic review and dose-response meta-analysis of randomized controlled trials Clinical Nutrition ESPEN. 2022. PMID: 36513480.
  2. 2.Yoneshiro T, Aita S, Kawai Y, Iwanaga T, Saito M. Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans American Journal of Clinical Nutrition. 2012. PMID: 22378725.

Plant-Based Protein on a GLP-1: What Closes the Gap, and Why the Drug Widens It

Across a full day at high protein intake a vegan diet matched an omnivorous one for muscle. Per meal, an omnivorous meal produced about 47% more muscle protein synthesis than a vegan one, and a GLP-1 works against the intake that closes the gap.

7 min read

GLP-1s During Ramadan: What the Four Studies Actually Tested

Four studies exist on taking a GLP‑1 through Ramadan and all four enrolled people with type 2 diabetes. Both randomized trials compared against a sulfonylurea, a drug class whose defining hazard is low blood sugar.

7 min read

Nutrition Drinks Alongside a GLP-1

A real-world study associated nutrition drinks with more fat loss and a better fat-to-lean ratio. The strongest effects were among people who complied, which is a compliance finding wearing a product's clothes.

5 min read

The Mediterranean Diet Trial That Measured Heart Attacks, Not Weight

CORDIOPREV randomized 1,002 people with coronary heart disease to a Mediterranean or low-fat diet for seven years and counted cardiovascular events: 87 against 111. The benefit was clear in men and undetected among the 175 women.

6 min read

GLP-1 Drugs and the Gut Microbiome: What 38 Studies Could Not Agree On

A systematic review of 38 studies found no single direction of effect. For semaglutide a beneficial bacterium rose while microbial diversity fell, and in the one randomized human study the bacterial shifts were not associated with glucose control at all.

6 min read

Protein Targets and the Lab Panel

At least 1.2 g of protein per kg daily, 0.3–0.4 g/kg per meal, and a short lab panel: vitamin D, B12, iron studies, folate and zinc, plus thiamin in high-risk patients. The upper protein target excludes chronic kidney disease.

5 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.8

DudeMeds

Compounded semaglutide at $175/month, prepaid as a 3-month kit

7.3

Ivim Health

Coaching and unlimited provider visits bundled into a 12-month compounded program

9.3

Embody

A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →